These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 1509855)
61. The quantitative determination of the paw-swelling activity of pertussis vaccine with special reference to its responsible toxic components. Ishida S; Iwasa S; Akama K; Asakawa S; Tai M; Kurokawa M Jpn J Med Sci Biol; 1983 Jun; 36(3):157-70. PubMed ID: 6685199 [TBL] [Abstract][Full Text] [Related]
62. Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers. Sato Y; Sato H Tokai J Exp Clin Med; 1988; 13 Suppl():79-88. PubMed ID: 2908530 [TBL] [Abstract][Full Text] [Related]
63. Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. Linthicum DS; Munoz JJ; Blaskett A Cell Immunol; 1982 Nov; 73(2):299-310. PubMed ID: 6891621 [No Abstract] [Full Text] [Related]
64. Transglutaminase and experimental allergic encephalomyelitis. The effects of encephalitogenic components in mice and guinea pigs. Wajda IJ; Lee JM; Waelsch H J Neurochem; 1967 Apr; 14(4):389-99. PubMed ID: 6022899 [No Abstract] [Full Text] [Related]
65. [Morphological alterations in animal organs after the injection of acellular pertussis vaccine with immunomodulator]. Zakharova NS; Agal'tsova SI; Shmeleva EI; Britsina MV; Ozeretskovskaia MN; Remova TN; Bazhanova IG; Mertsalova NU; Ermolova EV Zh Mikrobiol Epidemiol Immunobiol; 2003; (3):30-4. PubMed ID: 12886628 [TBL] [Abstract][Full Text] [Related]
66. [Effect of immunomodulators on adrenal glands of mice from various lines]. Bogomolova NV; Mit'kin VV; Kirillicheva GB; Ezepchuk IuV; Tumanian MA; Parkhomenko IuG; Sukhikh GT Biull Eksp Biol Med; 1991 Oct; 112(10):407-8. PubMed ID: 1804357 [No Abstract] [Full Text] [Related]
67. Specific unresponsiveness to skin allografts in mice. 3. Synergistic effect of tissue extracts, Bordetella pertussis, and antilymphocytic serum. Pinto M; Brent L; Thomas AV Transplantation; 1974 May; 17(5):477-86. PubMed ID: 4363833 [No Abstract] [Full Text] [Related]
69. Comparative toxicity, protective, histamine sensitizing and leucocytosis promoting activities in mice of Bordetella pertussis culture fluid, bacterial cells and cell extracts. Megret F; Fournier JM; Alouf JE Med Microbiol Immunol; 1984; 173(4):225-32. PubMed ID: 6096686 [TBL] [Abstract][Full Text] [Related]
70. Specificity and detection limit of a dermal temperature histamine sensitization test for absence of residual pertussis toxin in vaccines. Jensen SE; Illigen KE; Badsberg JH; Hasløv KR Biologicals; 2012 Jan; 40(1):36-40. PubMed ID: 22000164 [TBL] [Abstract][Full Text] [Related]
71. [Characteristics of immunomodulating effect of histamine in inbred strain mice]. Kirillicheva GB; Solov'eva MS; Baturina IG; Shchukovskaia TN; Maslennikov GA Biull Eksp Biol Med; 1992 Mar; 113(3):296-7. PubMed ID: 1421232 [TBL] [Abstract][Full Text] [Related]
72. An alternative temperature-based histamine-sensitisation test for absence of residual pertussis toxin in acellular pertussis vaccines. Jensen SE; Engelhart Illigen KE; Hasløv KR Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):73-4. PubMed ID: 20223192 [TBL] [Abstract][Full Text] [Related]
73. Comparison of the histamine sensitizing property with the protective activity of pertussis vaccines for mice. PITTMAN M J Infect Dis; 1951; 89(3):300-4. PubMed ID: 14888957 [No Abstract] [Full Text] [Related]
74. [Characteristics of the immune response to a single peroral administration of different doses of corpuscular pertussis vaccine]. Zakharova NS; Salov VF; Vlasov GS; Shepeleva IB; Sergeeva GS Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):76-81. PubMed ID: 2859723 [TBL] [Abstract][Full Text] [Related]
75. Glycerol-releasing activity of histamine-sensitizing factor of Bordetella pertussis for rat adipocytes in vitro. Endoh M; Nakase Y Microbiol Immunol; 1982; 26(8):689-703. PubMed ID: 6294484 [TBL] [Abstract][Full Text] [Related]
76. Requirement of thymus-dependent lymphocytes for potentiation by adjuvants of antibody formation. Allison AC; Davies AJ Nature; 1971 Oct; 233(5318):330-2. PubMed ID: 4940426 [No Abstract] [Full Text] [Related]
77. [Morpho-functional characteristics of lymph nodes in mice of different strains after administration of immunomodulators]. Borodin IuI; Sklianova NA; Sklianov IuI; Patrusheva SV Arkh Anat Gistol Embriol; 1990 Jul; 99(7):68-72. PubMed ID: 2252440 [TBL] [Abstract][Full Text] [Related]